Do Won Hwang

Title: Do Won Hwang: Innovator in Exosome Labeling and Polynucleotide Delivery

Introduction

Do Won Hwang is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the fields of nuclear medicine and gene delivery through his innovative patents. With a total of 2 patents, Hwang's work focuses on enhancing the efficiency and effectiveness of medical treatments.

Latest Patents

Hwang's latest patents include a method for labeling exosomes with a radioactive substance and a polynucleotide delivery complex for target cells. The first patent describes a method that involves treating the surface of cell-derived exosomes with N-hydroxysuccinimide-azadibenzocyclooctyne (NHS-ADIBO) and subsequently mixing it with a chelator-radioactive substance. This process allows for stable labeling of exosomes, which can be utilized in nuclear medicine imaging and therapeutic applications. The second patent presents a polynucleotide delivery system that incorporates a cationic polymer bound to a rabies virus glycoprotein (RVG) peptide. This innovative system aims to deliver polynucleotides effectively to target cells.

Career Highlights

Throughout his career, Do Won Hwang has worked with notable institutions such as the Postech Academy-Industry Foundation and the SNU RDB Foundation. His research has significantly advanced the understanding and application of exosomes in medical science.

Collaborations

Hwang has collaborated with esteemed colleagues, including Dong Soo Lee and Won Jong Kim, to further his research and innovations in the field.

Conclusion

Do Won Hwang's contributions to exosome labeling and polynucleotide delivery systems highlight his role as a key innovator in medical technology. His patents reflect a commitment to improving healthcare solutions through scientific advancements.